Terence G. Hamill - Concepedia

Author

Terence G. Hamill

Also Known As

T G Hamill, T Hamill, T. G. HAMILL, T. G. Hamill, T. Hamill, T.G. Hamill, Terence G Hamill, Terence G. Hamill, Terence Hamill

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Johns Hopkins University KU Leuven Johns Hopkins Medicine

About

Terence G. Hamill is an author at United States Military Academy specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	844
2	Natural Sciences	6	6	128
3	Engineering	4	4	124
4	Health Sciences	1	1	40
5	Public Health	1	1	33

Terence G. Hamill

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial John R. Petrie, Nish Chaturvedi, Ian Ford, The Lancet Diabetes & Endocrinology Metabolic SyndromeType 1Diabetes ManagementCardiovascular DiseaseDiabetes	2017	337
HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase Amy S. Espeseth, Peter J. Felock, Abigail Wolfe, Proceedings of the National Academy of Sciences	2000	317
[<sup>18</sup>F]MK-9470, a positron emission tomography (PET) tracer for<i>in vivo</i>human PET brain imaging of the cannabinoid-1 receptor H. Donald Burns, Koen Van Laere, Sandra Sanabria Bohórquez, Proceedings of the National Academy of Sciences	2007	311
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers Terence G. Hamill, Stephen M. Krause, Christine Ryan, Synapse	2005	152
<sup>18</sup>F-FPEB, a PET Radiopharmaceutical for Quantifying Metabotropic Glutamate 5 Receptors: A First-in-Human Study of Radiochemical Safety, Biokinetics, and Radiation Dosimetry Dean F. Wong, Rikki N. Waterhouse, Hiroto Kuwabara, Journal of Nuclear Medicine	2013	102
Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB Shil Patel, Terence G. Hamill, Brett Connolly, Nuclear Medicine and Biology G Protein-coupled ReceptorMglur5 Binding SitesMedicineReceptor (Biochemistry)Neuropeptide Receptor	2007	98
Nonpeptide α<sub>v</sub>β<sub>3</sub> Antagonists. 1. Transformation of a Potent, Integrin-Selective α<sub>IIb</sub>β<sub>3</sub> Antagonist into a Potent α<sub>v</sub>β<sub>3</sub> Antagonist Mark E. Duggan, Le T. Duong, John Fisher, Journal of Medicinal Chemistry	2000	88
Asymmetric michael additions of ester enolates to enantiomerically pure vinylic sulfoxides Gary H. Posner, Moshe Weitzberg, Terence G. Hamill, Tetrahedron Vinylic SulfoxidesEster EnolatesOrganic ChemistryStereoselective SynthesisChemistry	1986	67
Visualization and Quantification of Neurokinin-1 (NK1) Receptors in the Human Brain Jarmo Hietala, Mikko Nyman, Olli Eskola, Molecular Imaging and Biology NeurophysiologyMedicineNeurotransmitterImmunologyNeuropeptide Receptor	2005	64
Comparison of Binding to Rapidly Activating Delayed Rectifier K+ Channel, IKr, and Effects on Myocardial Refractoriness for Class III Antiarrhythmic Agents Joseph J. Lynch, Elizabeth Baskin, Elka M. Nutt, Journal of Cardiovascular Pharmacology	1995	57

Page 1